Cargando…
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination
(1) Background: Some COVID-19 vaccine recipients show breakthrough infection. It remains unknown, which factors contribute to risks and severe outcomes. Our aim was to identify risk factors for SCoV2 breakthrough infections in fully vaccinated individuals. (2) Methods: We conducted a retrospective c...
Autores principales: | Peter, Jelissa Katharina, Wegner, Fanny, Gsponer, Severin, Helfenstein, Fabrice, Roloff, Tim, Tarnutzer, Rahel, Grosheintz, Kerstin, Back, Moritz, Schaubhut, Carla, Wagner, Sabina, Seth-Smith, Helena M. B., Scotton, Patrick, Redondo, Maurice, Beckmann, Christiane, Stadler, Tanja, Salzmann, Andrea, Kurth, Henriette, Leuzinger, Karoline, Bassetti, Stefano, Bingisser, Roland, Siegemund, Martin, Weisser, Maja, Battegay, Manuel, Sutter, Sarah Tschudin, Lebrand, Aitana, Hirsch, Hans H., Fuchs, Simon, Egli, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146960/ https://www.ncbi.nlm.nih.gov/pubmed/35630302 http://dx.doi.org/10.3390/microorganisms10050857 |
Ejemplares similares
-
Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection
por: Leuzinger, Karoline, et al.
Publicado: (2021) -
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
por: Søgaard, Kirstine K., et al.
Publicado: (2021) -
Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study
por: Agnetti, Jessica, et al.
Publicado: (2023) -
SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event
por: Stange, Madlen, et al.
Publicado: (2021) -
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study
por: Lampart, Maurin, et al.
Publicado: (2022)